CD40, a member of the tumor necrosis factor receptor (TNFR) family, and its ligation have been shown to have anti-tumor effect via agonistic anti-CD40 mAbs to either directly kill CD40-positive tumor cells or activate T-cell immune responses [107, 108]. Here, CD40 is linked to neoplasm.